In order to assess the association between the above SNPs and the severity of liver diseases, Longo et al. silenced HepG2 cells for rs738409 PNPLA3, rs641738 MBOAT7, and rs58542926 TM6SF2 using the CRISPR/Cas9 technology [26]. This evidence concerns the gene PNPLA3 and liver disorder.